The comorbidity and co-medication profile of patients with progressive supranuclear palsy

被引：0

作者：

Stephan Greten

Florian Wegner

Ida Jensen

Lea Krey

Sophia Rogozinski

Meret Fehring

Johanne Heine

Johanna Doll-Lee

Monika Pötter-Nerger

Molly Zeitzschel

Keno Hagena

David J. Pedrosa

Carsten Eggers

Katrin Bürk

Claudia Trenkwalder

Inga Claus

Tobias Warnecke

Patrick Süß

Jürgen Winkler

Doreen Gruber

Florin Gandor

Daniela Berg

Steffen Paschen

Joseph Classen

Elmar H. Pinkhardt

Jan Kassubek

Wolfgang H. Jost

Lars Tönges

Andrea A. Kühn

Johannes Schwarz

Oliver Peters

Eman Dashti

Josef Priller

Eike J. Spruth

Patricia Krause

Annika Spottke

Anja Schneider

Aline Beyle

Okka Kimmich

Markus Donix

Robert Haussmann

Moritz Brandt

Elisabeth Dinter

Jens Wiltfang

Björn H. Schott

Inga Zerr

Mathias Bähr

Katharina Buerger

Daniel Janowitz

Robert Perneczky

机构：

[1] Hannover Medical School,Department of Neurology

[2] University Medical Center Hamburg-Eppendorf,Department of Neurology

[3] University Hospital of Marburg and Gießen,Department of Neurology

[4] Department of Neurology,Department of Neurology with Institute of Translational Neurology

[5] Kliniken Schmieder Stuttgart-Gerlingen,Department of Neurology and Neurorehabilitation

[6] Paracelsus-Elena Klinik,Department of Molecular Neurology

[7] University Hospital Muenster,Center of Rare Diseases Erlangen (ZSEER)

[8] Klinikum Osnabrueck-Academic Teaching Hospital of the WWU Muenster,Department of Neurology

[9] University Hospital Erlangen,Department of Neurology

[10] Friedrich-Alexander-Universität Erlangen-Nürnberg,Department of Neurology

[11] University Hospital Erlangen,Department of Neurology

[12] Friedrich-Alexander-Universität Erlangen-Nürnberg,Protein Research Unit Ruhr (PURE)

[13] Movement Disorders Hospital,Movement Disorder and Neuromodulation Unit, Department of Neurology

[14] Beelitz-Heilstätten,Department of Neurology

[15] Kiel University,Department of Psychiatry

[16] University of Leipzig Medical Center,Department of Neurology

[17] University of Ulm,Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar

[18] German Center for Neurodegenerative Diseases (DZNE),Department of Neurology

[19] Parkinson-Klinik Ortenau,Department of Neurodegenerative Diseases and Geriatric Psychiatry

[20] St. Josef-Hospital,Department of Psychiatry and Psychotherapy

[21] Ruhr University Bochum,Department of Neurology

[22] Neurodegeneration Research,Department of Psychiatry and Psychotherapy

[23] Ruhr University Bochum,Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences

[24] Charité,Department of Neurology

[25] University Medicine Berlin,Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)

[26] German Center for Neurodegenerative Diseases (DZNE),Institute for Stroke and Dementia Research

[27] Klinik Haag I. OB,Department of Psychiatry and Psychotherapy

[28] Charité-Universitätsmedizin Berlin,Ageing Epidemiology Research Unit, School of Public Health

[29] Charité-Universitätsmedizin Berlin,Department of Neurology

[30] Department of Psychiatry and Psychotherapy,Institute of Cognitive Neurology and Dementia Research

[31] Charité,Institute of Cognitive Neuroscience

[32] Technical University Munich,Clinic for Neurology, Medical Faculty

[33] German Center for Neurodegenerative Diseases (DZNE),Department of Psychosomatic Medicine

[34] University Hospital Bonn,Department of Neurology

[35] University Hospital Bonn,Department of Neurodegenerative Diseases

[36] German Center for Neurodegenerative Diseases (DZNE),Center for Geriatric Medicine

[37] University Hospital Carl Gustav Carus,undefined

[38] Technische Universität Dresden,undefined

[39] University Hospital Carl Gustav Carus,undefined

[40] Technische Universität Dresden,undefined

[41] German Center for Neurodegenerative Diseases (DZNE),undefined

[42] University Medical Center Goettingen,undefined

[43] University of Göttingen,undefined

[44] University of Aveiro,undefined

[45] University Medical Center,undefined

[46] Georg August University,undefined

[47] University Medical Center Göttingen,undefined

[48] German Center for Neurodegenerative Diseases (DZNE),undefined

[49] University Hospital,undefined

[50] LMU Munich,undefined

来源：

Journal of Neurology | 2024年 / 271卷

关键词：

Progressive supranuclear palsy; Comorbidities; Polypharmacy; Drug–drug interactions;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：782 / 793

页数：11

共 50 条

[1] The comorbidity and co-medication profile of patients with progressive supranuclear palsy
Greten, Stephan
Wegner, Florian
Jensen, Ida
Krey, Lea
Rogozinski, Sophia
Fehring, Meret
Heine, Johanne
Doll-Lee, Johanna
Poetter-Nerger, Monika
Zeitzschel, Molly
Hagena, Keno
Pedrosa, David J.
Eggers, Carsten
Buerk, Katrin
Trenkwalder, Claudia
Claus, Inga
Warnecke, Tobias
Suess, Patrick
Winkler, Juergen
Gruber, Doreen
Gandor, Florin
Berg, Daniela
Paschen, Steffen
Classen, Joseph
Pinkhardt, Elmar H.
Kassubek, Jan
Jost, Wolfgang H.
Toenges, Lars
Kuehn, Andrea A.
Schwarz, Johannes
Peters, Oliver
Dashti, Eman
Priller, Josef
Spruth, Eike J.
Krause, Patricia
Spottke, Annika
Schneider, Anja
Beyle, Aline
Kimmich, Okka
Donix, Markus
Haussmann, Robert
Brandt, Moritz
Dinter, Elisabeth
Wiltfang, Jens
Schott, Bjoern H.
Zerr, Inga
Baehr, Mathias
Buerger, Katharina
Janowitz, Daniel
Perneczky, Robert
JOURNAL OF NEUROLOGY, 2024, 271 (02) : 782 - 793
[2] Comorbidity and co-medication in a psychiatry ward
Peter, L.
Kovacs, G.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S213 - S213
[3] The language profile of progressive supranuclear palsy
Catricala, Eleonora
Boschi, Veronica
Cuoco, Sofia
Galiano, Francesco
Picillo, Marina
Gobbi, Elena
Miozzo, Antonio
Chesi, Cristiano
Esposito, Valentina
Santangelo, Gabriella
Pellecchia, Maria Teresa
Borsa, Virginia M.
Barone, Paolo
Garrard, Peter
Iannaccone, Sandro
Cappa, Stefano F.
CORTEX, 2019, 115 : 294 - 308
[4] Paranoid schizophrenia and progressive supranuclear palsy:: a fortuitous comorbidity?
Gallarda, T
Fabre, I
Willard, D
Olié, JP
INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 291 - 292
[5] Evaluation of supranuclear palsy rating scale in patients with progressive supranuclear palsy
Rai, N. K.
Goyal, V.
Shukla, G.
Kumar, N.
Shrivastava, A. K.
Behari, M.
MOVEMENT DISORDERS, 2013, 28 : S283 - S285
[6] Evaluation of supranuclear palsy rating scale in patients with progressive supranuclear palsy
Rai, N. K.
Goyal, V.
Kumar, N.
Shukla, G.
Srivastava, A. K.
Behari, M.
MOVEMENT DISORDERS, 2012, 27 : S390 - S391
[7] Fatigue in patients with progressive supranuclear palsy
Ahn, J. H.
Song, J.
Choi, I.
Lee, D. Y.
Youn, J.
Cho, J. W.
MOVEMENT DISORDERS, 2021, 36 : S250 - S251
[8] Complications in Patients with Progressive Supranuclear Palsy
Aiba, I.
Takigawa, H.
Hanajima, R.
Shimohata, T.
Morita, M.
Hasegawa, K.
Kowa, H.
Kanazawa, M.
Tokuda, T.
Tokumaru, A. M.
Nakashima, K.
Ikeuchi, T.
MOVEMENT DISORDERS, 2022, 37 : S486 - S486
[9] Progressive supranuclear palsy: Disease profile and rehabilitation strategies
Zampieri, Cris
Di Fabio, Richard P.
PHYSICAL THERAPY, 2006, 86 (06): : 870 - 880
[10] Neuropsychological profile of corticobasal degeneration, progressive supranuclear palsy and frontotemporal dementia patients
Carmona-Abellan, M. M.
Riverol, M.
Recio, M.
Echeveste, B.
Imaz, L.
Luquin, R.
MOVEMENT DISORDERS, 2017, 32

← 1 2 3 4 5 →